肾脏健康倡议:推进远程监测技术助力居家肾脏替代治疗患者自我管理
远程医疗在心力衰竭、糖尿病等慢病中已较普及,但在居家肾脏替代治疗(RRT)中应用滞后,现有研究多为小样本单中心。肾脏健康倡议组织多学科工作组梳理了居家RRT远程监测的现状、利弊、实施障碍与关键未解问题,认为该技术有望提高居家透析接受度、改善结局与满意度并可能降低成本。
要点
- 居家RRT远程监测研究多为小样本单中心,缺乏结局与成本效果数据。
- 支付方与联邦/州法规需与远程医疗流程对齐,并需理解各方利益相关者观点。
- 远程医疗有潜力提高居家透析接受度、改善结局与满意度并可能降低成本。
核心结论
- 远程医疗在居家RRT中应用滞后,但有望提高居家透析接受度、改善结局与患者满意度,并可能降低成本。
研究设计与样本
- 肾脏健康倡议召开多学科工作组,审视居家RRT远程医疗应用现状并梳理利弊、实施障碍与关键未解问题。
主要发现
- 远程医疗已应用于心力衰竭、糖尿病、高血压和慢性阻塞性肺疾病,但在居家RRT中 uptake 滞后。
- 现有RRT远程医疗研究规模小且为单中心,缺乏结局与成本效果数据以指导未来决策。
临床怎么用
- 需推动支付方与政府法规同远程医疗流程对齐,并理解患者、照护者、临床医生、支付方、透析机构和监管者等各方观点。
局限性
- 现有RRT远程医疗研究规模小且为单中心,缺乏结局与成本效果数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Telehealth and remote monitoring of a patient's health status has become more commonplace in the last decade and has been applied to conditions such as heart failure, diabetes mellitus, hypertension, and chronic obstructive pulmonary disease. Conversely, uptake of these technologies to help engender and support home RRTs has lagged. Although studies have looked at the role of telehealth in RRT, they are small and single-centered, and both outcome and cost-effectiveness data are needed to inform future decision making. Furthermore, alignment of payer and government (federal and state) regulations with telehealth procedures is needed along with a better understanding of the viewpoints of the various stakeholders in this process (patients, caregivers, clinicians, payers, dialysis organizations, and government regulators). Despite these barriers, telehealth has great potential to increase the acceptance of home dialysis, and improve outcomes and patient satisfaction while potentially decreasing costs. The Kidney Health Initiative convened a multidisciplinary workgroup to examine the current state of telehealth use in home RRTs as well as outline potential benefits and drawbacks, impediments to implementation, and key unanswered questions.
引用
- Rosner MH, Lew SQ, Conway P, et al. Perspectives from the Kidney Health Initiative on Advancing Technologies to Facilitate Remote Monitoring of Patient Self-Care in RRT. Clin J Am Soc Nephrol. 2017. PMID: 28710094. doi:10.2215/CJN.12781216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。